Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC8 | Q9BY41 | 4/20 | 0.48 |
| ▸ | APOBEC3A | P31941 | 2/20 | 0.35 |
| ▸ | APOBEC3G | Q9HC16 | 2/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14972849 | 0.83 | HDAC8 (0.45) | HDAC8APOBEC3AAPOBEC3GPOLBCTDSP1 | |
| SCHEMBL23698040 | 0.67 | HDAC8 (0.38) | HDAC8 | |
| SCHEMBL329129 | 0.65 | — | — | |
| SCHEMBL427788 | 0.65 | HDAC8 (0.35) | HDAC8APOBEC3AAPOBEC3GPOLBCTDSP1 | |
| SCHEMBL425516 | 0.64 | HDAC8 (0.33) | HDAC8 | |
| SCHEMBL486560 | 0.64 | HDAC8 (0.48) | HDAC8APOBEC3AAPOBEC3GPOLBCTDSP1 | |
| SCHEMBL422096 | 0.64 | HDAC8 (0.33) | HDAC8 | |
| SCHEMBL12201262 | 0.64 | — | — | |
| SCHEMBL22349236 | 0.64 | — | — | |
| SCHEMBL12279963 | 0.64 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115772094-A | Oximation method of cyclododecanone | 万华化学集团股份有限公司 | 2023-03-10 | — | — | CN | claimed |
| CN-115772094-B | Cyclododecanone is to be oximated | 万华化学集团股份有限公司 | 2024-09-10 | — | — | CN | disclosed |
| CN-113437359-B | Preparation method of polypropylene oxide polymer solid electrolyte film | 长沙矿冶研究院有限责任公司 | 2023-04-07 | — | — | CN | disclosed |
| CN-115772094-A | Oximation method of cyclododecanone | 万华化学集团股份有限公司 | 2023-03-10 | — | — | CN | disclosed |
| CN-114195651-A | Underwater adhesive and preparation method thereof | 浙江工业大学 | 2022-03-18 | — | — | CN | disclosed |
| EP-3567027-B1 | METHOD FOR PRODUCING N-BENZYL-2-BROMO-3-METHOXYPROPIONAMIDE AND INTERMEDIATES THEREOF | API CORP (JP) | 2022-01-19 | — | — | EP | disclosed |
| US-11136287-B2 | Method for producing n-benzyl-2-bromo-3-methoxypropionamide and intermediates thereof | API CORPORATION (JP) | 2021-10-05 | — | — | US | disclosed |
| CN-113437359-A | Preparation method of polypropylene oxide polymer solid electrolyte film | 长沙矿冶研究院有限责任公司 | 2021-09-24 | — | — | CN | disclosed |
| CN-111787998-B | Composite semipermeable membrane and composite semipermeable membrane element | 东丽株式会社 | 2021-08-24 | — | — | CN | disclosed |
| CN-113121347-A | Acrylic ester compound for preparing spiro lactone, spiro lactone and preparation method thereof | 黄淮学院 | 2021-07-16 | — | — | CN | disclosed |
| CN-111787997-B | Composite semipermeable membrane and composite semipermeable membrane element | 东丽株式会社 | 2021-05-25 | — | — | CN | disclosed |
| CN-111787998-A | Composite semipermeable membrane and composite semipermeable membrane element | 东丽株式会社 | 2020-10-16 | — | — | CN | disclosed |
| CN-111787997-A | Composite semipermeable membrane and composite semipermeable membrane element | 东丽株式会社 | 2020-10-16 | — | — | CN | disclosed |
| CN-110536743-B | Composite semipermeable membrane and method for producing same | 东丽株式会社 | 2020-07-07 | — | — | CN | disclosed |
| US-20200115322-A1 | METHOD FOR PRODUCING N-BENZYL-2-BROMO-3-METHOXYPROPIONAMIDE AND INTERMEDIATES THEREOF | API CORPORATION (JP) | 2020-04-16 | — | — | US | disclosed |
| EP-3567027-A1 | N-BENZYL-2-BROMO-3-METHOXYPROPIONAMIDE AND METHOD FOR PRODUCING INTERMEDIATE THEREOF | API Corporation (JP) | 2019-11-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200115322-A1 | METHOD FOR PRODUCING N-BENZYL-2-BROMO-3-METHOXYPROPIONAMIDE AND INTERMEDIATES THEREOF | NAAA, BRD2, PAM | HDAC8 3351/4885APOBEC3A 90/4885APOBEC3G 119/4885 |
| US-11136287-B2 | Method for producing n-benzyl-2-bromo-3-methoxypropionamide and intermediates thereof | NAAA, BRD2, PAM | HDAC8 3351/4885APOBEC3A 90/4885APOBEC3G 119/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.